雜志介紹

Tumori Journal雜志介紹

《Tumori Journal》是一本以English為主的未開放獲取國際優秀期刊，中文名稱腫瘤雜志，本刊主要出版、報道醫學-ONCOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2，最新CiteScore 指數為3.5。

本刊近期中國學者發表的論文主要有：

• Differences in clinical features and prognosis between orbit adenoid cystic carcinoma and adenocarcinoma: a study from the SEER 18 database

  Author: Liu, Rui; Li, Jing; Zhang, Xuan; Ge, Xin; Ma, Jianmin

• Alternatively-spliced lncRNA-PNUTS promotes HCC cell EMT via regulating ZEB1 expression

  Author: Zhao, Haiyan; Liu, Chang; Zhao, Chongyu; Che, Chi; Liu, Wuguang; Mei, Yan

• Cardiovascular toxicity associated with the multitargeted tyrosine kinase inhibitor anlotinib

  Author: Zhao, Shu; Wang, Peng; Yin, Fan; Wu, Junjie; Wang, Yuying; Li, Peng; Zhang, Yong; Yang, Jing; Guo, Xueguang; Zhang, Dong; Song, Peng

• Patients with brain metastases from gastric cancer

  Author: Yang, Yu; Yang, Yang; Chen, Zhendong

英文介紹

Tumori Journal雜志英文介紹

Tumori Journal covers all aspects of cancer science and clinical practice with a strong focus on prevention, translational medicine and clinically relevant reports. We invite the publication of randomized trials and reports on large, consecutive patient series that investigate the real impact of new techniques, drugs and devices inday-to-day clinical practice.